Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid Malignancies
Clinical trial NCT03394144 · COMPLETED
Trial details
- NCT number
- NCT03394144
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-30
- Primary completion
- 2019-04-12
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.